scout.yahoo.com
Yahoo Scout
Yahoo Scout
(biontech
Searching…
Web results
www.biontech.com
BioNTech: Advancing science to help transform cancer and...
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.
en.wikipedia.org
BioNTech - Wikipedia
BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies ...
investors.biontech.de
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation...
Mar 10, 2026 · BioNTech co-founders and mRNA technology pioneers Prof. Ugur Sahin, M.D., and Prof. Özlem Türeci, M.D., will establish their third biotechnology company following the foundation of Ganymed Pharmaceutica...
www.nasdaq.com
BioNTech and Co-Founders Announce Plan to Pursue Next ... -...
Mar 10, 2026 · BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanning immunomodulator, ADC and mRNA candidates BioNTech co-founders Ugur Sahin and Özlem Türeci ...
finance.yahoo.com
BioNTech Cofounder Exits Put Leadership Transition And Pipeline...
Mar 22, 2026 · BioNTech (NasdaqGS:BNTX) cofounders Ugur Sahin and Özlem Türeci are leaving their roles as CEO and Chief Medical Officer. Both executives plan to launch a new startup, triggering a leadership ...
www.dw.com
BioNTech founders step down to start new venture - dw.com
Mar 10, 2026 · The husband-and-wife founders of German vaccine company BioNTech announced on Tuesday they would step down to pursue new innovations at a brand new firm.
www.reuters.com
BioNTech SE | Reuters
Mar 3, 2026 · The latest international BioNTech SE news and views from Reuters - one of the world's largest news agencies
simplywall.st
BioNTech (NasdaqGS:BNTX) Valuation Check After New Lung Cancer...
3 days ago · Clinical data spotlight raises questions for BioNTech (NasdaqGS:BNTX) investors BioNTech (NasdaqGS:BNTX) has put its oncology ambitions in focus after presenting fresh lung cancer data at the European Lun...
www.nytimes.com
BioNTech’s Founders on A.I. and the Future of Cancer Treatment -...
Dec 5, 2023 · Dr. Ugur Sahin and Dr. Özlem Türeci are pioneers in the field of mRNA vaccines and personalized cancer immunotherapies, and are the scientific founders of BioNTech.
capital.com
BioNTech stock forecast: Co-founders’ exit, weaker 2026 guidance
3 days ago · BioNTech stock forecast: Co-founders’ exit, weaker 2026 guidance BioNTech is a German biotechnology company whose shares have come under pressure after weaker 2026 revenue guidance and a reported Q4 2025 ...